Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 24.5 to 18.2.
Financials
Financial year 2025
STREPYDIS from La Louvière, company number BE0732580919, closed financial year 2025 with a result of € -170,658 after tax. For that financial year STREPYDIS recorded a gross margin of € 672,725 and equity of € 275,711. Compared with financial year 2024, the result moved from € 135,414 to € -170,658. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 275,711
▼ 38% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -170,658
▼ still € 135,414 profit in 2024
Profit after tax over the fiscal year.
€ 152,223
▼ 63% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 175,711.
People and assets in 2025
18.2
▼ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 642,914
▼ 7% vs 2024
€ 35,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 31,584
▲ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 90,840
▼ 42% vs 2024
€ 8,294 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 604,990
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 94,657
▼ 10% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,116,747 | € 995,275 | € 1,093,909 | € 672,725 | ▼ 39% |
| Profit after taxes | € 21,398 | € -71,380 | € 135,414 | € -170,658 | ▼ € 306,072 |
| Equity | € 382,336 | € 310,956 | € 446,370 | € 275,711 | ▼ 38% |
| Total debts | € 1,388,346 | € 1,178,441 | € 1,003,414 | € 828,580 | ▼ 17% |
| Cash | € 665,119 | € 421,974 | € 411,641 | € 152,223 | ▼ 63% |
| Land & buildings | € 178,758 | € 158,358 | € 135,159 | € 111,970 | ▼ 17% |
| Retained profit | € 282,336 | € 210,956 | € 346,370 | € 175,711 | ▼ 49% |
| Bank debt | € 422,739 | € 265,417 | € 155,887 | € 90,840 | ▼ 42% |
| Balance sheet total | € 1,770,682 | € 1,489,396 | € 1,449,784 | € 1,104,291 | ▼ 24% |
| Employees (FTE) | 27 | 24.5 | 19.1 | 18.2 | ▼ 0.9 |
Key figures of STREPYDIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to STREPYDIS?
What happened at STREPYDIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 170,658 (▼ € 306,072 vs 2024). Source: NBB ↗
- New establishment in La Louvière. KBO
- Cateno Sanguine became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 21,398 profit in 2022 to € 170,658 loss in 2025.
Paid € 38,212 in corporate taxes since 2022.
Best year ever: 2024, with € 135,414 profit.
On average € 37,000 of value added per employee in 2025.
A new publication or filing at STREPYDIS? We notify you, reason included.
Follow STREPYDISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind STREPYDIS is Cateno Sanguine. Cateno Sanguine is also behind MESTDAGH, SUPERLOG, Evolica, HOUDINIS and Lovidis.
Establishments
Establishment units
Physical locations of this company
Rue de l'Indépendance(S-B) 81
7110 La Louvière
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0732.580.919
- VAT number
- BE 0732.580.919
- Registered office
- Rue de l'Indépendance(S-B) 81, 7110 La Louvière
- Names & denominations
- STREPYDIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 13 August 2019
- Peppol
- Active · Active since 12 Dec 2025
- Activities · NACE
Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte tussen 400 m² en minder dan 2500 m²)